2012-11-14 – Page 8 – China Stock Advice

SORL [SORL Auto Parts] 10-Q:

[] [of the Sarbanes-Oxley Act of 2002 I, Xiao Ping Zhang, certify that: 1. I have reviewed this Form 10-Q of SORL AUTO PARTS, INC.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under] [Certification of Principal Financial Officer of the Sarbanes-Oxley Act of 2002 I, Zong Yun Zhou, certify that: 1. I have reviewed this Form 10-Q of SORL AUTO PARTS, INC.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in] [(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Sorl Auto Parts, Inc. Xiao Ping Zhang Chief Executive Officer and President Zong Yun Zhou Chief Financial Officer and Treasurer (Principal Financial Officer)]

By info| 2016-03-26T21:40:10+00:00 November 14th, 2012|Categories: Chinese Stocks, SORL, Webplus ver|Tags: 0000714284, 10-Q, 2012-11-14, 3714, MOTOR VEHICLE PARTS and ACCESSORIES, SORL|0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL] 10-Q: (Original Filing)

[SKYSTAR BIO-PHARMACEUTICALMPANY FORM10-Q INDEX Page No. 3 PART I.FINANCIAL INFORMATION 4 Item 1.ndensednsolidated Financial Statements 4ndensednsolidated Balance Sheets of September 30, 2012 (Unaudited) and December 31, 2011 4ndensednsolidated Statements ofome andmprehensiveome for the Three Months and Nine Months Ended September 30, 2012 and 2011 (Unaudited)] [SECTION 302 OF THERBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this quarterly report on Form 10-Q ofystar Bio-Pharmaceuticalmpany; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [SECTION 302 OF THERBANES-OXLEY ACT OF 2002 I, Bing Mei, certify that: 1. I have reviewed this quarterly report on Form 10-Q ofystar Bio-Pharmaceuticalmpany; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [(2)The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany. Weibing Lu, Chief Executive Officer v327445_ex32-1.htm 4 EX-32.1] [(2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany. Bing Mei, Chief Financial Officer v327445_ex32-2.htm 5 EX-32.2]

By info| 2016-02-05T03:02:29+00:00 November 14th, 2012|Categories: Chinese Stocks, SEC Original, SKBI|Tags: 0001076939, 10-Q, 2012-11-14, 2834, PHARMACEUTICAL PREPARATIONS, SKBI|0 Comments

VIPS [Vipshop] 6-K: (Original Filing)

[Vipshop Holdings Limited Donghao Yang Chief Financial Officer 2 3 Vipshop Reports Third Quarter 2012 Financial Results Achieves Non-GAAP Net Income Profitability 3Q12 Net Revenues Up 197.0% YOY]

By info| 2016-03-12T23:16:14+00:00 November 14th, 2012|Categories: Chinese Stocks, SEC Original, VIPS|Tags: 0001529192, 2012-11-14, 5961, 6-K, RETAIL-CATALOG and MAIL-ORDER HOUSES, VIPS|0 Comments

KNDI [Kandi Technologies] 10-Q: FORM 10-Q For the quarterly period ended September

[FORM 10-Q For the quarterly period ended September 30, 2012 or For the transition period from _____________ to _____________. Kandi Technologies, Corp. Delaware 90-0363723 (State or other jurisdiction of (I.R.S. Employer Identification No.) incorporation or organization) Jinhua City Industrial Zone Jinhua, Zhejiang Province Peoples Republic of China Post Code 321016 ___________ (86 - 579) 82239856 Yes [X] No [_] Yes] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Hu Xiaoming, certify that: 1. I have reviewed this report on Form 10-Q of Kandi Technologies, Corp.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Zhu Xiaoying, certify that: 1. I have reviewed this report on Form 10-Q of Kandi Technologies, Corp.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [18 U.S.C. § 1350, § 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.]

By info| 2016-03-18T14:15:14+00:00 November 14th, 2012|Categories: Chinese Stocks, KNDI, Webplus ver|Tags: 0001316517, 10-Q, 2012-11-14, 3711, KNDI, MOTOR VEHICLES and PASSENGER CAR BODIES|0 Comments

TPI [TIANYIN PHARMACEUTICAL] 10-Q: (Original Filing)

[FORM 10-Q (Mark One) x For the quarterly period ended September 30, 2012 o For the transition period from _______________ to _______________ Tianyin Pharmaceutical Co., Inc. Delaware (State or other jurisdiction of incorporation or organization) 23rd Floor, Unionsun Yangkuo Plaza No. 2, Block 3, Renmin Road South Chengdu, P. R. China, 610041 +0086-028-86154737 (Address, including zip code, and telephone number,] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER I, Guoqing Jiang certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended September 30, 2012 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make] [CERTIFICATION OF CHIEF FINANCIAL OFFICER I, James Jiayuan Tong, certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended September 30, 2012 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Guoqing Jiang Guoqing Jiang Chief Executive Officer, Chief Accounting Officer & Chairman] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. James Jiayuan Tong James Jiayuan Tong Chief Financial Officer, Director]

By info| 2016-03-27T18:59:55+00:00 November 14th, 2012|Categories: Chinese Stocks, SEC Original, TPI|Tags: 0001362718, 10-Q, 2012-11-14, 2834, PHARMACEUTICAL PREPARATIONS, TPI|0 Comments